The TME Stimulation model that we have used in this study has combined the hormonal, inflammatory and growth-promoting arms of the TME; however other arrays of TME setups can be active in HR+/HER2− breast tumors, as well as in other malignancies. Here, HR is linked to breast neoplasm.